United Kingdom · Question · Written question
UIN 243
Diabetes: Semaglutide
Introduced
7 November 2023
Last action
17 November 2023 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
17 November 2023
Summary
To ask the Secretary of State for Health and Social Care, whether he is taking steps to increase the availability of Ozempic pens for patients with type 2 diabetes.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
7 November 2023
Written question
To ask the Secretary of State for Health and Social Care, whether he is taking steps to increase the availability of Ozempic pens for patients with type 2 diabetes.
Source: Commons
17 November 2023
Answer
We are aware of a supply issue with glucagon-like peptide 1 receptor agonist (GLP-1 RA) medicines, including Ozempic pens. We have issued guidance in the form of Medicine Supply Notifications and, on 18 July 2023, issued a National Patient Safety Alert wi...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2023-11-07/243
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1667632
- uk · wq-1667632 · source updated 17 November 2023